🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is a clinical trial of a new combination of drugs as a ...
Status
Completed
Location
Boston Children's Hospital
Start Date
2020-12-23
Trial ID
NCT04661852
Treatments Being Tested
It is expected that addition of anti-CD20 antibody - ofatumumab would enhan...
Status
Completed
Location
Dolnośląskie Centrum Transplantacji Komórkowych
Start Date
2011-11
Trial ID
NCT01481272
This phase I trial studies the side effects and best dose of wee1 kinase in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05-25
Trial ID
NCT02791919
Phase I trial to study the effectiveness of oblimersen plus combination che...
Status
Completed
Location
Children's Oncology Group
Start Date
2002-11
Trial ID
NCT00039481
Allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) is a recog...
Status
Completed
Location
CHU Amiens
Start Date
2016-02-23
Trial ID
NCT02623309
Treatments Being Tested
The goal of this clinical research study is to learn if intensive chemother...
Status
Completed
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2002-08
Trial ID
NCT00669877
Treatments Being Tested
This phase IV trial compares the effect of premedication regimens with meth...
Status
Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2025-09-24
Trial ID
NCT07101445
Prospective, single-center, single-blind, randomized, controlled, two-arm, ...
Status
Completed
Location
Leuven University Fertility Center
Start Date
2014-11-25
Trial ID
NCT02586272
Treatments Being Tested
The systemic vasculitis is a wide-ranging group of diseases that are charac...
Status
Terminated
Location
Northwestern University, Feinberg School of Medicine
Start Date
2003-08
Trial ID
NCT00278512
This phase I/II trial finds the best dose, side effects and how well giving...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-02-04
Trial ID
NCT04797767